News and Announcements
GlaxoSmithKline Extends Service Agreement with MedAdvisor
- Published June 16, 2016 2:19PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
16th June 2016, ASX Announcement
Highlights
- GlaxoSmithKline (GSK) Australia extends its services agreement with MedAdvisor for a further 12 months.
- GSK will continue utilising MedAdvisor’s medication management platform to provide relevant information for patients prescribed three medicines within GSK Australia’s respiratory portfolio.
- Agreement will generate Patient Engagement Program (PEP), formerly knows as Medication Training and Adherence Campaigns (MTAC), revenue for MedAdvisor.
- Allows GKS Australia to leverage the MedAdvisor platform to support patients on the safe and effective use of these medicines.
MedAdvisor Limited (ASX: MDR, the Company), Australia’s leading digital medication adherence company, is pleased to announce that the Australian arm of leading global pharmaceutical company, GlaxoSmithKline Australia Pty (GSK) has extended its services agreement with MedAdvisor for a further 12 months.
Under the agreement, GSK Australia will continue providing tailored messages to patients prescribed medicines with GSK Australia’s respiratory portfolio.
To view the full announcement, please click on the button below.
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
